Serum C reactive protein predicts humoral response after BNT162b2 booster administration

J Infect. 2022 Jul;85(1):e24-e25. doi: 10.1016/j.jinf.2022.04.015. Epub 2022 Apr 8.

Authors

Gian Luca Salvagno¹, Brandon M Henry², Laura Pighi¹, Simone De Nitto¹, Giuseppe Lippi³

Affiliations

¹ Section of Clinical Biochemistry, University of Verona, Verona, Italy; Service of Laboratory Medicine, Pederzoli Hospital, Peschiera del Garda, Italy.
² Clinical Laboratory, Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
³ Section of Clinical Biochemistry, University of Verona, Verona, Italy. Electronic address: giuseppe.lippi@univr.it.

No abstract available

Keywords: Antibodies; C reactive protein; COVID-19; SARS-CoV-2; Vaccination.

Publication types

Letter

MeSH terms

Antibodies, Viral
BNT162 Vaccine*
C-Reactive Protein*
Humans
Immunity, Humoral
Immunization, Secondary
Vaccination

Substances

Antibodies, Viral
C-Reactive Protein
BNT162 Vaccine